Health By Helen Branswell U.S. urges pause on use of Johnson & Johnson Covid-19 vaccine after rare blood clotting cases
The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein AstraZeneca’s latest vaccine woes, the compassionate use dilemma, & what it’s like to give out Covid vaccines
Politics By Lev Facher Biden officials rebuff appeals to surge Covid-19 vaccine to Michigan amid growing crisis
Health By Helen Branswell and Matthew Herper In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say
First Opinion By Dinesh Thakur India shouldn’t insist on ‘bridging trials’ in the middle of a pandemic
Health By Helen Branswell STAT+ Conversations: A conversation on how to find that elusive Covid-19 vaccine
First Opinion By John Stanford Thank private risk-taking, not public funding, for Covid-19 vaccines, therapies
STAT Madness By Elizabeth Cooney An HIV lab’s pivot to develop a single-dose Covid-19 vaccine wins STAT Madness ‘Editors’ Pick’
Politics By Lev Facher Resistance from health experts and business owners could doom ‘vaccine passports’ even before they launch
First Opinion By Julia Barnes-Weise and Kendall Hoyt MAPGuide: A tool to help improve health-related public-private partnership agreements
By Nicholas Florko The operation formerly known as Warp Speed: Biden leans heavily on the flagship Trump-era initiative
Pharmalot By Ed Silverman Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries
Politics By Nicholas Florko and Andrew Joseph ‘Right now I’m scared’: CDC director warns of a coming spike in Covid-19 case counts
First Opinion By Robert Klitzman How will people act after getting vaccinated? The complex psychology of safety
Health By Usha Lee McFarling A user’s guide: How to talk to those hesitant about the Covid-19 vaccine
The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein AstraZeneca and the very good, then quite bad, then deeply confusing week
Pharmalot By Ed Silverman HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access
First Opinion By Jonathan Shaffer Biden should use emergency powers to license Covid-19 vaccine technologies to the WHO for global access
